KalVista Pharmaceuticals
KALV
KALV
68 hedge funds and large institutions have $398M invested in KalVista Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.33% more ownership
Funds ownership: 77.28% → 80.61% (+3.3%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
Holders
68
Holding in Top 10
7
Calls
–
Puts
–
Top Buyers
| 1 | +$30.6M | |
| 2 | +$21M | |
| 3 | +$2.76M | |
| 4 |
O
OrbiMed
New York
|
+$2.59M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.86M |
Top Sellers
| 1 | -$20.5M | |
| 2 | -$9M | |
| 3 | -$5.31M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$4.99M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$3.03M |